Live from the NIH registry
Studies recruiting near Surprise right now
Top 25 of 982 recruiting studies, sorted by proximity — each links to its official registry page
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
Bone Graft; Complications, ACL Injuries
N/A
Interventional 75 participants sought
Banner University Medical Center Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: University of Arizona
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Mayo Clinic in Arizona - Phoenix- Site Number : 8400005 — Phoenix, Arizona (27.1 mi)
· Sponsor: Sanofi
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
Alzheimer's Disease, Dementia
N/A
Observational 500,000 participants sought
Banner Alzheimer's Institute — Phoenix, Arizona (27.1 mi)
· Sponsor: Banner Health
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Arizona Arthritis & Rheumatology Associates (AARA) - Glendale — Glendale, Arizona (18.2 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Phoenix Retina Clinical Trials, LLC — Phoenix, Arizona (27.1 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Phoenix Childrens Hospital - Thomas Rd - PIN — Phoenix, Arizona (27.1 mi)
· Sponsor: Takeda
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Clinical Research Inst of Arizona — Sun City West, Arizona (6.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Arizona Research Center, Inc. — Phoenix, Arizona (27.1 mi)
· Sponsor: Novo Nordisk A/S
A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Phase 2
Interventional 70 participants sought
Pulmonary Associates - Phoenix - East McDowell Road- Site Number : 8400008 — Phoenix, Arizona (27.1 mi)
· Sponsor: Sanofi
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
Xenoscience Inc — Phoenix, Arizona (27.1 mi)
· Sponsor: Pfizer
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early Onset Alzheimer Disease, Alzheimer Disease
N/A
Observational 850 participants sought
Banner Sun Health Research Institute — Sun City, Arizona (11.9 mi)
· Sponsor: Indiana University
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 150 participants sought
Medical Dermatology Specialist — Phoenix, Arizona (27.1 mi)
· Sponsor: Navigator Medicines, Inc.
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
REmote Virtual Inspiration: Vitality and Energy
Implementation Science, Women Health
N/A
Interventional 280 participants sought
Arizona State University — Phoenix, Arizona (27.1 mi)
· Sponsor: Arizona State University
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Arizona Arthritis & Rheumatology Associates — Glendale, Arizona (18.2 mi)
· Sponsor: Elevara Medicines Limited
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer)
Phase 1
Interventional 140 participants sought
Mayo Clinic — Phoenix, Arizona (27.1 mi)
· Sponsor: Nuvectis Pharma, Inc.
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
City of Hope - Phoenix — Goodyear, Arizona (17.8 mi)
· Sponsor: Sellas Life Sciences Group
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
Gentamicin Bladder Instillation on CAUTI
Catheter Infection
Phase 4
Interventional 400 participants sought
St. Jpseph's Hospital and Medical Center — Phoenix, Arizona (27.1 mi)
· Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Schizophrenia
Phase 3
Interventional 690 participants sought
Reviva site — Phoenix, Arizona (27.1 mi)
· Sponsor: Reviva Pharmaceuticals
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Mayo Clinic Hospital in Arizona — Phoenix, Arizona (27.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Phoenix, Arizona (27.1 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Litchfield Park, Arizona (14.1 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.